Dipicolinic Acid

Dipicolinic Acid

SCHEMBL720696

O=C(O)c1cccc(C(=O)O)n1.O=C(O)c1cccc(C(=O)O)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
ALOX15 P16050 2/20 1.00
TSHR P16473 2/20 1.00
ACMSD Q8TDX5 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
GNE Q9Y223 1/20 0.61
LMNA P02545 3/20 0.57
NAPRT Q6XQN6 1/20 0.54
P4HTM Q9NXG6 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MGAM O43451 1/20 0.54
KMT2A Q03164 2/20 0.54
HIF1A Q16665 1/20 0.52
POLB P06746 1/20 0.52
ECE1 P42892 1/20 0.50
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipicolinic Acid SCHEMBL34595 1.00 KDM4E (1.00) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL11294102 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL15659942 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL9659122 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL6561776 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL3974347 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL3732330 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL2276248 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL6556692 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL9491853 0.97 KDM4E (0.94) KDM4EALOX15TSHRACMSDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120052134-A1 SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS ECOLAB USA INC. (US) 2012-03-01 US disclosed
WO-2011087786-A1 HYDROGEN PEROXIDE COMPOSITIONS AND CLEANING FORMULATIONS PREPARED THEREFROM ARKEMA INC. (US) 2011-07-21 WO disclosed
WO-2011036628-A2 SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS ECOLAB INC. (US) 2011-03-31 WO disclosed
EP-2271616-A2 SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS Ecolab INC. (US) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052134-A1 SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS GPX4, PRDX1, PRDX4 KDM4E 1084/4885ALOX15 7/4885TSHR 3839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.